Pharma Reviews: Lockdown impact | India using multi-pronged strategy to contain COVID-19: USAIC

Terming India's 21-day nationwide lockdown as a "bold and difficult" decision, a top Indian-American pharma industry expert on March 26 said that the ...
Read more: Lockdown impact | India using multi-pronged strategy to contain COVID-19: USAIC